PMC:7278327 / 8593-8880 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"295","span":{"begin":272,"end":282},"obj":"Species"},{"id":"316","span":{"begin":64,"end":72},"obj":"Disease"}],"attributes":[{"id":"A295","pred":"tao:has_database_id","subj":"295","obj":"Tax:2697049"},{"id":"A316","pred":"tao:has_database_id","subj":"316","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"acious preventive measure against neurological comorbidities of COVID 19. This hypothesis is based on critical evaluation of the current biomedical literature. Currently, however, there are no vaccines in development that are designed to specifically target or neutralize SARS-CoV-2 entr"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T69","span":{"begin":64,"end":72},"obj":"Disease"},{"id":"T70","span":{"begin":272,"end":280},"obj":"Disease"}],"attributes":[{"id":"A69","pred":"mondo_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"acious preventive measure against neurological comorbidities of COVID 19. This hypothesis is based on critical evaluation of the current biomedical literature. Currently, however, there are no vaccines in development that are designed to specifically target or neutralize SARS-CoV-2 entr"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T42","span":{"begin":74,"end":159},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"acious preventive measure against neurological comorbidities of COVID 19. This hypothesis is based on critical evaluation of the current biomedical literature. Currently, however, there are no vaccines in development that are designed to specifically target or neutralize SARS-CoV-2 entr"}